Key Market Segments
By Product
- Reagents and Assay Kits
- Instruments
- Consumables and Accessories
- Software and Data Analysis Tools
- Services
- Others (calibration standards, maintenance kits)
By Technique
- Chromatography
- Spectroscopy
- Differential Scanning Calorimetry (DSC)
- Differential Scanning Fluorimetry (DSF)
- Dynamic Light Scattering (DLS)
- Surface Plasmon Resonance (SPR)
By Application
- Drug Discovery and Development
- Biopharmaceutical Production
- Disease Diagnosis and Biomarker Research
- Protein Engineering
- Quality Control and Regulatory Compliance
By End-User
- Pharmaceutical & Biotechnology Companies
- Contract Research Organizations (CROs)
- Academic and Research Institutes
- Others (government laboratories, food & beverage industry labs)
Request for Segment Customization as per your Business Requirement: Segment Customization Request
Regional Coverage:
North America
- US
- Canada
Europe
- Germany
- France
- UK
- Italy
- Spain
- Russia
- Poland
- Rest of Europe
Asia Pacific
- China
- India
- Japan
- South Korea
- Australia
- Rest of Asia Pacific
Middle East & Africa
- UAE
- Saudi Arabia
- Qatar
- Egypt
- South Africa
- Rest of Middle East & Africa
Latin America
- Brazil
- Argentina
- Mexico
- Colombia
- Rest of Latin America
Request for Country Level Research Report: Country Level Customization Request
Available Customization
With the given market data, SNS Insider offers customization as per the company’s specific needs. The following customization options are available for the report:
- Detailed Volume Analysis
- Criss-Cross segment analysis (e.g., Product X Application)
- Competitive Product Benchmarking
- Geographic Analysis
- Additional countries in any of the regions
- Customized Data Representation
- Detailed analysis and profiling of additional market players
Frequently Asked Questions
Ans: It helps optimize drug formulation, shelf-life, and efficacy, reducing the risk of clinical trial failures due to protein instability.
Ans: Growth is fueled by advancements in thermal analysis, AI integration, and high-throughput screening platforms for biologics.
Ans: Key players include Thermo Fisher Scientific, Agilent Technologies, NanoTemper Technologies, Waters Corporation, and PerkinElmer, among others.
Ans: The pharmaceutical, biotechnology, and contract research industries are key drivers due to rising demand for stability-indicating methods in drug development.
Ans: The market is projected to surpass USD 2.37 billion in 2025, driven by increasing demand for biologics and biosimilar development.